<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05042960</url>
  </required_header>
  <id_info>
    <org_study_id>21-00472</org_study_id>
    <nct_id>NCT05042960</nct_id>
  </id_info>
  <brief_title>Computer Screen Properties Study</brief_title>
  <official_title>Investigating the Effects of Screen Brightness and Warm Tone Modulation on Dry Eye Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify how various popular methods of changing computer&#xD;
      screen settings affect dry eye symptoms (eye pain, grittiness, tearing, burning, etc.).&#xD;
      Specifically, this study will examine if there are differences in effects of blue light&#xD;
      blocking (F.lux app or night shift) versus reducing screen brightness on the symptoms of dry&#xD;
      eye.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After the initial survey, participants will be randomized by a randomization tool internal to&#xD;
      Redcap to be in one of three arms of intervention: no intervention, screen brightness&#xD;
      reduction to 50%, and tone modulator application. Instructions will be e-mailed to&#xD;
      participants to explain the steps they must take depending on which treatment arm they are&#xD;
      randomized to. Adherence will be monitored and assessed at the time of post-intervention&#xD;
      survey. If participants have issues with the software of complying, they will be able to&#xD;
      contact the research team at any point.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 15, 2021</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The frequency of dry eye symptoms</measure>
    <time_frame>Day 1</time_frame>
    <description>Participants will complete a pre-intervention survey to measure the frequency of dry eye symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The frequency of dry eye symptoms</measure>
    <time_frame>Day 30</time_frame>
    <description>Participants will complete a post-intervention survey to measure the frequency of dry eye symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The severity of dry eye symptoms</measure>
    <time_frame>Day 1</time_frame>
    <description>Participants will complete a pre-intervention survey to measure the severity of dry eye symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The severity of dry eye symptoms</measure>
    <time_frame>Day 30</time_frame>
    <description>Participants will complete a post-intervention survey to measure the severity of dry eye symptoms.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Dry Eye Syndromes</condition>
  <arm_group>
    <arm_group_label>50% brightness group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be using a computer screen reducing screen brightness 50%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Light App group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will use a modulating computer screen tone with flux or night shift app.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in this group will be a control with no change in screen features</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Brightness</intervention_name>
    <description>Changing the colors or brightness on the device (computer screen) for one month</description>
    <arm_group_label>50% brightness group</arm_group_label>
    <arm_group_label>Light App group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult person (18+) with intact vision who uses computers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children (&lt;18 years)&#xD;
&#xD;
          -  Adult person without intact vision&#xD;
&#xD;
          -  Adult who does not use computer screens&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leela Raju, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sachi Patil</last_name>
    <phone>631-793-2594</phone>
    <email>Sachi.patil@nyulangone.org</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 3, 2021</study_first_submitted>
  <study_first_submitted_qc>September 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2021</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Immediately following publication. No end date.</ipd_time_frame>
    <ipd_access_criteria>Requests should be directed to sachi.patil@nyulangone.org To gain access, data requestors will need to sign a data access agreement. Researchers who provide a methodologically sound proposal.Upon reasonable request</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

